Skip to main navigation Skip to search Skip to main content

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in Subjects with ISN/RPS Class III or IV Lupus Nephritis

    Project: Research

    Project Details

    StatusActive
    Effective start/end date02/1/06 → …